Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
Status:
Completed
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
A combination of lopinavir/ ritonavir, ribavirin and interferon beta-1b will expedite the
recovery, suppress the viral load, shorten hospitalisation and reduce mortality in patients
with 2019-n-CoV infection compared with to lopinavir/ ritonavir